Entity
  • Genmab

    Created in 1999


  • Up & running (A)
    Existing signals show a regular activity
  • Social networks

    8,160 112,479
  • Entity types

  • Location

    Carl Jacobsens Vej 30, 2500 København, Denmark

    København

    Denmark

  • Employees

    Scale: 1001-5000

    Estimated: 2,623

  • Engaged catalyst

    11
    0 0
  • Added in Motherbase

    2 years ago
Description
  • Value proposition

    We are an international biotech company committed to our goal of improving the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, our passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational, quantitative, and data sciences, which has resulted in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators, and effector function enhanced antibodies. By 2030, our vision is to transform the lives of people with cancer and other serious diseases with knock-your-socks-off (KYSO®) antibody medicines. We are united by our core values: a passion for innovation, determination, integrity, and working as one team and respecting each other. When you work at Genmab you'll be part of a warm, fun, dynamic community seeking out and embracing the opportunity to build new and bold futures within a rapidly growing biotechnology company. Genmab is a place where you can be authentically you; you are empowered to innovate, build solutions and execute; you feel cared for and supported. In its totality, this makes working at Genmab an extra[not]ordinaryTM experience. Established in 1999, we are headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com.
    Disclaimer: http://bit.ly/GENDisclaimer

Catalyst interactions
Catalyst TypeTweets Articles
Nasdaq
Nasdaq
Finance, Financial Services
Nasdaq
Finance, Financial Services
Other

11 May 2021


Social network dynamics
Loading...